BIOMX INC (PHGE) Stock Earnings & Estimates
NYSEARCA:PHGE - US09090D3017 - Common Stock
0.5397 USD
-0.01 (-1.53%)
0.515 USD
-0.02 (-4.58%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 46.54% | N/A 334.91% | N/A 127.54% | N/A 54.06% | |||||||
| EBITDA YoY % growth | N/A | -80K | -28.08M -35,000.00% | -32.89M -17.13% | -24.7M 24.90% | -24.477M 0.90% | -34.636M -41.50% | N/A -38.12% | N/A -17.70% | N/A -18.12% | N/A 27.15% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -400K | -30.26M -7,465.00% | -35.46M -17.18% | -27.22M 23.24% | -25.348M 6.88% | -36.439M -43.75% | N/A 5.55% | N/A -17.68% | N/A -17.11% | N/A -0.18% | N/A -57.19% | N/A 69.17% | N/A 390.31% | N/A 130.23% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -13.00 -537.25% | -13.90 -6.92% | -9.40 32.37% | -5.30 43.62% | N/A 50.83% | N/A 25.64% | N/A 27.37% | N/A -10.51% | N/A 21.64% | N/A -31.38% | N/A 70.06% | N/A 344.68% | N/A 129.57% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.39 24.00% | -0.41 41.82% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | -9.996M -3.64% | -11.118M -46.31% |
| EBIT Q2Q % growth | -7.57M 28.09% | -7.619M 18.96% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.19 72.86% | -0.33 | 0.14 | 42.68% |
| Q1 2025 Q2Q % growth | -0.37 75.33% | -0.37 | 0.00 | -0.76% |
| Q4 2024 Q2Q % growth | -0.71 11.25% | -1.12 | 0.41 | 36.43% |
| Q3 2024 Q2Q % growth | 60.77% | -0.51 | % | |
| Q2 2024 Q2Q % growth | -0.70 41.67% | -0.88 | 0.18 | 20.82% |
| Q1 2024 Q2Q % growth | -1.50 25.00% | -1.17 | -0.33 | -27.88% |
| Q4 2023 Q2Q % growth | -0.80 57.89% | -1.12 | 0.32 | 28.70% |
| Q3 2023 Q2Q % growth | -1.30 43.48% | -1.02 | -0.28 | -27.45% |
| Q2 2023 Q2Q % growth | -1.20 52.00% | -1.48 | 0.28 | 18.86% |
| Q1 2023 Q2Q % growth | -2.00 25.93% | -1.79 | -0.21 | -12.04% |
| Q4 2022 Q2Q % growth | -1.90 48.65% | -2.35 | 0.45 | 19.01% |
| Q3 2022 Q2Q % growth | -2.30 37.84% | -2.32 | 0.02 | 0.88% |
| Q2 2022 Q2Q % growth | -2.50 16.67% | -2.75 | 0.25 | 9.22% |
| Q1 2022 Q2Q % growth | -2.70 22.86% | -2.99 | 0.29 | 9.76% |
| Q4 2021 Q2Q % growth | -3.70 5.13% | -2.86 | -0.84 | -29.55% |
| Q3 2021 Q2Q % growth | -3.70 2.63% | -3.11 | -0.59 | -18.93% |
| Q2 2021 Q2Q % growth | -3.00 -11.11% | -3.67 | 0.67 | 18.30% |
| Q1 2021 Q2Q % growth | -3.50 -34.62% | -3.37 | -0.13 | -3.98% |
| Q4 2020 Q2Q % growth | -3.90 -91.18% | -3.64 | -0.26 | -7.20% |
| Q3 2020 Q2Q % growth | -3.80 | -2.70 | -1.10 | -40.58% |
| Q2 2020 Q2Q % growth | -2.70 | -2.19 | -0.51 | -23.12% |
| Q1 2020 Q2Q % growth | -2.60 | -2.19 | -0.41 | -18.56% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | 765K | -765K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 7.32% | -660% | -24.18% | -24.18% |
| Revenue | N/A | N/A | N/A | N/A |